Champions Oncology, Inc.

CSBRNASDAQUSD
6.63 USD
0.55 (9.05%)AT CLOSE (11:59 AM EDT)
6.51
0.12 (1.81%)
POST MARKET (AS OF 04:22 PM EDT)
Post Market
AS OF 04:22 PM EDT
6.51
0.12 (1.81%)
🔴Market: CLOSED

Champions Oncology, Inc. (CSBR) is currently trading at $6.63. CSBR shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, CSBR trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jun 26, 2026.

Open?$6.01
High?$6.63
Low?$6.01
Prev. Close?$6.08
Volume?15.5K
Avg. Volume?8.7K
VWAP?$6.17
Rel. Volume?1.78x
Bid / Ask
Bid?$5.16 × 100
Ask?$9.06 × 100
Spread?$3.90
Midpoint?$7.11
Valuation & Ratios
Market Cap?92.1M
Shares Out?13.9M
Float?5.1M
Float %?36.4%
P/E Ratio?N/A
P/B Ratio?21.50
EPS?-$0.16
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
Employees
306
Market Cap
84.4M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
1994-10-31
Address
855 N. WOLFE STREET
BALTIMORE, MD 21205
Phone: 410-369-0365
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
3
Momentum?
73
Short Sent.?
65
Piotroski F-Score?1/9Weak
Altman Z-Score?0.06Distress
Confidence?50%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?1.55%Low
Short Interest?78.5K
Days to Cover?12.6
Free Float5.1M
Avg Daily Volume6.2K
Settlement Date2026-06-15
Financial Health
Current Ratio?0.98Weak
Quick Ratio?0.98Weak
Cash Ratio?0.34Low
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
80/100
P/E?
N/A
P/B?
Peers
100
S&P
6
21.50HIGH
P/S?
Peers
100
S&P
77
1.59CHEAP
P/FCF?
Peers
100
S&P
41
24.1FAIR
EV/EBITDA?
S&P
97
-109.9CHEAP
EV/Sales?
Peers
100
S&P
84
1.47CHEAP
Returns & Efficiency
ROE?
S&P
3
-53.3%WEAK
ROA?
S&P
3
-8.0%WEAK
Cash Flow & Enterprise
FCF?$3.8M
Enterprise Value?$84.9M
Fundamentals ratios updated end of day